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Abstract
Unraveling the causes and pathomechanisms of progressive disorders is essential for the development of therapeutic strate-
gies. Here, we identified heterozygous pathogenic missense variants of LMX1A in two families of Dutch origin with pro-
gressive nonsyndromic hearing impairment (HI), using whole exome sequencing. One variant, c.721G > C (p.Val241Leu), 
occurred de novo and is predicted to affect the homeodomain of LMX1A, which is essential for DNA binding. The second 
variant, c.290G > C (p.Cys97Ser), predicted to affect a zinc-binding residue of the second LIM domain that is involved in 
protein–protein interactions. Bi-allelic deleterious variants of Lmx1a are associated with a complex phenotype in mice, 
including deafness and vestibular defects, due to arrest of inner ear development. Although Lmx1a mouse mutants demon-
strate neurological, skeletal, pigmentation and reproductive system abnormalities, no syndromic features were present in the 
participating subjects of either family. LMX1A has previously been suggested as a candidate gene for intellectual disability, 
but our data do not support this, as affected subjects displayed normal cognition. Large variability was observed in the age of 
onset (a)symmetry, severity and progression rate of HI. About half of the affected individuals displayed vestibular dysfunction 
and experienced symptoms thereof. The late-onset progressive phenotype and the absence of cochleovestibular malforma-
tions on computed tomography scans indicate that heterozygous defects of LMX1A do not result in severe developmental 
abnormalities in humans. We propose that a single LMX1A wild-type copy is sufficient for normal development but insuf-
ficient for maintenance of cochleovestibular function. Alternatively, minor cochleovestibular developmental abnormalities 
could eventually lead to the progressive phenotype seen in the families.
Introduction
Hereditary nonsyndromic hearing impairment (NSHI, MIM: 
500008) is genetically very heterogeneous. Currently, more 
than 100 deafness genes have been identified, and still every 
year novel ones are discovered (Hereditary Hearing Loss 
Homepage). Since 2010, whole exome sequencing (WES) 
and targeted next generation sequencing have enabled the 
rapid and cost-efficient identification of deafness genes 
(Vona et al. 2015). However, we need to beware of seem-
ingly causative variants that segregate in small families or 
occur in several unique individuals with hearing impairment 
(HI) by coincidence, especially in dominant NSHI. This is 
illustrated by the recent disqualification of MYO1A (MIM: 
601478) as a deafness gene (Eisenberger et al. 2014; Patton 
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et al. 2016). Ideally, unique pathogenic variants are identi-
fied in several families with a similar phenotype and not in 
a significant number of controls. Genetic studies are prefera-
bly supported by functional and animal studies that prove the 
deleterious effect of a variant and demonstrate the function 
of a gene in hearing. As this is often very time-consuming 
and expensive, (homology) protein modeling or existing data 
on studies in mice can be supportive in the discovery of 
novel deafness genes, as was recently exemplified by KITLG 
(MIM: 184745) (Zazo Seco et al. 2015) and S1PR2 (MIM: 
605111) (Santos-Cortez et al. 2016).
The identification of genetic defects underlying progres-
sive HI and the pathomechanisms paves the way for devel-
opment of therapeutic strategies. In the present study, we 
identified pathogenic missense variants of LMX1A (MIM: 
600298), a gene associated with a complex phenotype in 
mice, including recessive deafness and vestibular defects 
(Bergstrom et al. 1999; Chizhikov et al. 2006; Steffes et al. 
2012), as a cause of dominant NSHI and vestibular dysfunc-
tion in humans.
Materials and methods
Study subjects
This study was approved by the medical ethics committee 
of the Radboud University Medical Center and is in accord-
ance with the principles of the World Medical Association 
Declaration of Helsinki. Written informed consent was 
obtained from all participants or their legal representatives. 
Medical history was obtained, using a questionnaire focus-
ing on hearing and balance. External ear inspection and 
otoscopy to assess the tympanic membrane and aeration of 
the middle ear were performed in all subjects. Special atten-
tion was paid to possible causes of acquired HI. Pure tone 
audiometry was performed in a sound-treated room accord-
ing to current standards. Air conduction thresholds were 
determined at 0.25, 0.5, 1, 2, 4, and 8 kHz in dB HL. Bone 
conduction thresholds were determined at 0.5, 1, 2, 4, and 
8 kHz in dB HL to exclude conductive HI. HI was described 
according to the recommendations of the GENDEAF study 
group (Mazzoli et al. 2003). Individual progression of HI 
was calculated for each frequency with longitudinal linear 
regression analyses, using GraphPad Prism 6.0 (GraphPad, 
San Diego, CA, USA). Tympanometry was performed, and 
click-evoked ABR and otoacoustic emissions (OAEs) were 
obtained, according to current standards. Contralateral 
and ipsilateral acoustic reflexes were measured at 0.5, 1, 
2 and 4 kHz up to loudness discomfort level. Speech per-
ception thresholds and maximum speech recognition scores 
were determined using speech audiometry, which was per-
formed in a sound-treated room with standard monosyllabic 
consonant–vowel–consonant Dutch word lists (Bosman and 
Smoorenburg 1995). Family 63136 did not participate in our 
clinical evaluation, but retrospective data from the affected 
subjects (I:2, II:2, II:3 and II:4) were analyzed.
Vestibular function was assessed in subjects II:7 and III:8 
(family W15-0551) and the index case of family 63136, 
using electronystagmography (ENG) rotary chair stimulation 
and caloric irrigation testing, according to current standards. 
Additionally, cervical vestibular evoked myogenic poten-
tials (cVEMP) and video head impulse tests (vHIT) were 
performed in subjects II:7 and III:8 of family W15-0551 to 
assess sacculus and vestibulo–ocular reflex (VOR) function-
ality, respectively.
To assess the presence of sub/infertility or neurologi-
cal, cognitive or cutaneous abnormalities, subjects were 
screened in accordance with a predefined protocol (Supple-
mental Methods).
Genetic analyses
WES
For WES, the exome was enriched with an Agilent Sure-
Select kit, version 4 or 5 (Santa Clara, CA, USA), and 
WES was performed on an Illumina HiSeq system by BGI 
Europe (Denmark) (Zazo Seco et al. 2017). As a first step, 
variants in genes associated with HI were selected (gene 
list DGD20062014) and classified according to the existing 
guidelines from the Association for Clinical Genetic Science 
and the Dutch Society of Clinical Genetic Laboratory Spe-
cialists (Wallis et al. 2013), as described previously (Zazo 
Seco et al. 2017). Mean ≥ 20× coverage was obtained for 
96% for the enriched regions.
Variants in WES, shared by individuals II:3 and II:4 of 
family 63136 were filtered as follows: variation reads ≥ 5 
and ≥ 20% and ≤ 90%, minor allele frequency (MAF) in in-
house WES database (~ 20,000 exomes) ≤ 0.05%, MAF in 
EXAC ≤ 0.05%, MAF in GnomAD (Exomes non-Finnish 
Europeans) ≤ 0.05%, and location in exons or in introns 
in the 20 bps flanking the exons. Missense variants were 
only selected for segregation analysis if at least two of four 
tools predicted pathogenicity. Tools employed were CADD 
(predicted pathogenic if ≥ 15), SIFT (predicted patho-
genic ≤ 0.05), Polyphen-2 (predicted pathogenic if ≥ 0.450) 
and Mutation Taster. A potential effect on splicing was pre-
dicted using the tools SpliceSiteFinder-like, MaxEntScan, 
NNSPLICE, GeneSplicer, and Human Splicing Finder as 
available in Alamut Visual (v 2.10, Interactive Biosoftware).
SNP genotyping (family 63136)
All members of family 63136 were genotyped with the 
 Infinium® Global Screening Array-24 v.1.0 (Illumina) 
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according to protocols of the manufacturer. Genotypes were 
employed to exclude candidate variants derived from WES. 
Variants were regarded to be excluded if genotypes of SNPs 
located within 0.5 Mb both proximal and distal of the variant 
excluded the presence of the haplotype with the variant in at 
least one affected individual.
Sanger sequencing
PCR of fragments to be analyzed was performed using stand-
ard protocols. Primers for PCR were designed with Primer-
3Plus. Reference sequence identifiers, primer sequences and 
PCR conditions are provided in Table S3. PCR fragments 
were purified with ExoSAP-IT (Thermo Fisher Scientific), 
according to manufacturers’ protocols. For sequence analysis, 
the ABI PRISM BigDye Terminator Cycle Sequencing v2.0 
Ready Reaction kit and the ABI PRISM 3730 DNA analyzer 
(Applied Biosystems, Foster City, CA, USA) were employed. 
Possibly deleterious effects of the identified variants were pre-
dicted with Alamut Visual version 2.7.1 (Interactive Biosoft-
ware, Rouen, France).
Linkage analysis
Linkage analysis was performed by genotyping of all subjects 
of family W15-0551 with the 700 K SNP Global Screening 
Array (Illumina, San Diego, CA, USA), using the manufac-
turers’ protocols. Superlink online SNP 1.1 software was 
employed for approximate multipoint LOD score calculations 
and a window size of 20 SNPs was used (Silberstein et al. 
2013). The inheritance pattern of HI was assumed to be auto-
somal dominant with a disease allele frequency of 0.001. The 
penetrance of the disease allele was set at 99%.
VNTR marker analysis
Haplotypes in the LMX1A region were determined by geno-
typing variable number of tandem repeat (VNTR) markers. 
Touchdown PCR was used to amplify the VNTR markers, and 
analyses were performed on an ABI Prism 3730 Genetic Ana-
lyzer (Applied Biosystems, Foster City, CA, USA). Marker 
heterozygosity, order, and genetic location were derived from 
the Marshfield genetic map. Alleles were assigned with Gen-
eMapper v.4.0 software (Applied Biosystems, Foster City, CA, 
USA).
Conservation in the LIM‑homeodomain protein 
family
All ~ 600 members of the family were extracted from the 
SMART domain database (http://smart .embl-heide lberg .de/) 
and aligned. Sequence logos for the second LIM domain 
and the homeodomain within this family were created with 
WebLogo (Crooks et al. 2004).
Results
A de novo missense variant of LMX1A cosegregates 
with dominant NSHI
A family of Dutch origin (W15-0551, Fig. 1a) was investi-
gated to identify the underlying genetic defect of the domi-
nant NSHI segregating in the family. We performed WES 
in the index case (III:8). No (likely) pathogenic variants 
were identified in genes known to be associated with HI. 
As a next step, all WES variants were analyzed. To reduce 
the number of candidate variants, WES was performed 
in subject II:7 as well. After filtering for shared and rare 
(≤ 0.5%), missense, nonsense, indels, and splice site vari-
ants, 186 variants remained (Table S1). One of these vari-
ants was a heterozygous missense variant of LMX1A at 
g.165179962C (GRCh37/hg19), and c.721G > C (RefSeq 
NM_001174069.1; p.Val241Leu) (Figure S1). This variant 
has not been reported in gnomAD and segregated with the 
HI in the family (Fig. 1a).
It was unknown whether the grandmother (subject I:2) 
was hearing impaired, because of conflicting subjective 
information provided by family members. Therefore, we 
investigated whether the variant of LMX1A was inher-
ited or occurred de novo in subject II:7. Haplotypes of 
VNTR markers in the LMX1A region were determined. 
This revealed that the c.721G > C containing haplotype 
was also present in individuals in the second generation, 
who did not carry this variant (Fig. 1a). This indicates 
that the variant occurred de novo in subject II:7 and also 
that the LMX1A genomic region would have been excluded 
to carry the underlying genetic defect if linkage analysis 
would have been the primary step in our analysis.
LMX1A c.721G is highly conserved (PhyloP 5.53) and 
p.Val241 is fully conserved in the LIM-homeodomain 
protein family (Fig. 2). Also, defects of Lmx1a have been 
associated with HI and vestibular defects in mouse (Berg-
strom et al. 1999; Chizhikov et al. 2006; Steffes et al. 
2012). All together, we considered the identified LMX1A 
variant a promising candidate to underlie the HI in family 
W15-0551.
To exclude other candidate DNA variants (n = 185) 
shared by individuals II:7 and III:8, linkage analysis was 
performed by genotyping all subjects of family W15-
0551. There were 54 regions in which linkage could not 
be excluded by a LOD score ≤ − 2 (Figure S2, Table S2). 
DNA variants in these regions were filtered and classified 
as described above, which resulted in seven candidate vari-
ants (Table S2). None of these segregated with the HI in 
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the family, as determined by Sanger sequencing. As ten 
of the 54 regions not excluded by linkage analysis har-
bored known deafness genes (Table S2), coverage of all 
exons and exon–intron boundaries of these genes, includ-
ing MYO6 (MIM: 600970), was manually checked to be 
at least 10×. Subsequently, Sanger sequencing was per-
formed for regions with a lower coverage, which did not 
reveal any rare variants (allele frequency ≤ 0.5%). Since 
the HI associated with dominant defects of MYO6 is simi-
lar to that in the affected subjects of family W15-0551 with 
regard to (variable) age of onset and severity (Hilgert et al. 
2008; Miyagawa et al. 2015), this gene was also excluded 
by segregation analysis of SNPs located in and flanking 
this gene (Figure S3).
Rare variants in the region of chromosome 6 with the 
strongest evidence for linkage were evaluated for a potential 
deleterious effect on gene function and for the genes carry-
ing the variants (SLC17A5, PM20D1, MDN1), we searched 
relevant databases for indications for a role in inner ear 
function (Table S3). All variants were intronic and none of 
these were predicted to affect transcript splicing (Table S3). 
Although MDN1 is transcribed in the cochlea at a significant 
level and HI is associated with Slc17a5 defects in mouse, it 
is not likely that the variants of these genes are contributing 
to the HI phenotype in the family or to the variability of this 
phenotype.
The p.Cys97Ser amino acid substitution of LMX1A 
is associated with NSHI
We addressed further involvement of deleterious LMX1A 
variants in dominant NSHI. WES data of individuals with 
NSHI, in which (likely) pathogenic variants in all known 
deafness genes were excluded, were evaluated for rare 
variants of LMX1A. Only subjects with suspected domi-
nant inheritance or without family history of HI were 
included (n = 405). This revealed a heterozygous variant at 
g.165218851, c.290G > C (p.Cys97Ser) in the index case 
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Fig. 1  Pedigrees, VNTR genotypes and segregation of LMX1A vari-
ants. a Genotypes of VNTR markers and segregation of the identified 
missense variant of LMX1A in family W15-0551. Genetic locations of 
the markers were derived online from the Marshfield genetic map and 
maker order was confirmed in the human genome assembly GRCh37/
hg19. As the variant resides on an allele (depicted in red) that is 
shared by non-affected siblings of subject II:7, the variant was con-
cluded to be de novo in subject II:7. It remained unclear whether sub-
ject I:2 was affected only at high age or earlier, based on conflicting 
subjective information provided by her family members. b Pedigree 
and segregation analyses of a missense variant in LMX1A in family 
63136. Index cases are indicated by arrows. + Wild type (color figure 
online)
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of family 63136 (Figure S1), which segregated with domi-
nantly inherited HI in the family (Fig. 1b). LMX1A c.290G 
is highly conserved (PhyloP 5.45) and variant c.290G > C 
has not been reported in the gnomAD database. Residue 
Cys97 is located within the second LIM domain, and is fully 
conserved in the LIM-homeodomain protein family (Fig. 2). 
Screening of WES data also revealed a heterozygous variant 
at g.165218765, c.376G > A (p.Gly126Lys) in the index case 
of family W05-233, but this variant was inherited from the 
normal hearing mother. As can be seen in Fig. 2, p.Gly126 
is not conserved in the LIM-homeodomain protein family.
To address other potentially pathogenic variants in fam-
ily 63136, in genes not (yet) associated with HI, WES was 
performed for an additional individual (II:4) of the family. 
Shared variants were identified and filtered as described in 
“Materials and methods” and SNP genotypes were employed 
to address potential co-segregation with the HI in the family. 
Based on these analyses, 15 candidate variants remained 
to be tested for segregation analysis by Sanger sequencing. 
Five of the 15 variants, all missense variants, were found to 
completely segregate with the HI in the family (Table S4a). 
However, no HI phenotype was reported for four of the five 
genes carrying the variants in mouse mutants (Table S4b) 
which does not support a causative nature of these variants 
for the HI in the family. For TTYH1, no phenotypic data 
were available for mouse mutants. We searched WES data 
of the genetically ‘unsolved’ cases with suspected dominant 
inheritance or without family history of HI for rare variants 
of this gene and did not identify any rare truncating or mis-
sense variants or variants predicted to affect splicing.
LMX1A‑associated HI is nonsyndromic, 
sensorineural, and progressive with a variable age 
of onset
The affected subjects of family W15-0551 (II:7, III:8 and 
IV:2) were clinically examined to characterize their audi-
ovestibular phenotype. There was no evidence of acquired 
LIM HOXLIM
Fig. 2  Domains and conservation of (mutated) residues in the LIM-
homeodomain protein family. The presented conservation of the 
second LIM domain and the homeodomain shows that the mutated 
residues Cys97 and Val241 (indicated by arrows) are perfectly con-
served. Within the second LIM domain, the residues that together 
bind two zinc atoms are indicated with black lines above the amino 
acid sequence
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causes of HI. All affected subjects had sensorineural HI 
except for individual II:7 of family W15-0551, who had 
bilateral fenestral otosclerosis and mixed HI of the left ear. 
We assumed that the sensorineural HI was unlikely to be 
caused by otosclerosis, because there were no signs of coch-
lear otosclerosis on computed tomography scans and her 
vestibular test results fit with the defect in LMX1A. There 
were no preoperative audiograms available before stapedec-
tomy of the right ear in 1973 for comparison of the pre- and 
postoperative bone conduction thresholds of the right ear.
The reported age of onset varied from congenital to 
35 years (Table 1). Affected subjects had mild to profound 
HI with overall a downsloping audiogram configuration 
(Fig. 3). Subject IV:2 of family W15-0551 and subject II:2 
of family 63136 displayed asymmetric HI, whereas the other 
affected individuals demonstrated symmetric HI. Longitudi-
nal linear regression analysis of hearing thresholds revealed 
significant progression in all affected subjects of both fami-
lies, except for subject IV:2 of family W15-0551, probably 
because follow-up time was too short (3 years) to measure 
significant deterioration of hearing in this individual. Pro-
gression of HI was not analyzed in subject II:7 of family 
W15-0551, as we cannot exclude deterioration of hearing 
due to her otosclerosis. The progression rate and severity 
of HI varied widely among the affected subjects (Fig. 3, 
Table 1).
Speech reception thresholds were lower than or compa-
rable to pure tone average thresholds at 0.5, 1 and 2 kHz 
for the better hearing ear, indicating the absence of retro-
cochlear pathology (Table 1). This is confirmed by results 
from acoustic reflex measurements in all affected subjects 
and brainstem evoked response audiometry in subject II:2 of 
family 63136, which showed no indications of retrocochlear 
pathology (data not shown). CT scans in subject II:7 of fam-
ily W15-0551 and the index case (II:3) of family 63136 did 
not show cochleovestibular malformations, except for known 
fenestral otosclerosis in the former individual.
Four out of seven affected individuals reported sudden 
episodes of vertigo in the past that lasted minutes to days, 
with or without tinnitus, but without simultaneous deterio-
ration of hearing (Table 1). Individuals could not identify 
triggers for the vertigo episodes. Vestibular function was 
assessed in subjects II:7 and III:8 (family W15-0551) and 
the index case of family 63136. The vestibular tests revealed 
bilateral symmetric hyporeflexia in subject III:8 of family 
W15-0551 (42-year-old), asymmetric severe hyporeflexia to 
areflexia to the detriment of the left vestibulum in subject 
II:3 of family 63136 (52-year-old), and bilateral areflexia in 
subject II:7 of family W15-0551 (73-year-old). Subjects II:7 
and III:8 of family W15-0551 also underwent a video head 
impulse test (vHIT) and cervical vestibular evoked myo-
genic potential (cVEMP) recordings. The vHIT displayed 
bilateral weakness of the posterior semicircular canals in 
individual II:7 and normal function in individual III:8. 
cVEMPs showed no responses up to 100 dBnHL in both 
subjects, indicating dysfunction of the saccule. An overview 
of vestibular test results is presented in Table S6. Besides 
standard vestibular tests, subjects also underwent oculo-
motor testing, consisting of smooth pursuit, gaze (frontal/
right/left), saccade, optokinetic and spontaneous nystagmus 
tests. Oculomotor testing revealed no abnormalities (data not 
shown). Since vestibular abnormalities are more severe in 
the older individuals, we hypothesize that there is progres-
sive deterioration of vestibular function. There were, how-
ever, no longitudinal data available to confirm this.
As mice with bi-allelic loss-of-function variants of Lmx1a 
display neurological, skeletal, pigmentation, and reproduc-
tive system abnormalities, besides HI and vestibular dys-
function (Bergstrom et al. 1999; Chizhikov et al. 2006; 
Steffes et al. 2012), the affected subjects of families W15-
0551 and 63136 were screened for syndromic abnormali-
ties (Supplemental Methods). However, none of the affected 
individuals of families W15-0551 and 63136 displayed any 
cutaneous abnormalities, signs of cognitive dysfunction, or 
peripheral or central nervous system involvement. History 
taking did not indicate fertility problems.
Discussion
This study provides evidence that LMX1A is involved in 
hearing and vestibular function. In two families of Dutch ori-
gin, mono-allelic deleterious variants of Lmx1a were found 
to be associated with a progressive phenotype. HI started 
between birth and the age of 35 years, and severity and pro-
gression rate varied widely between affected individuals. 
About half of the affected individuals displayed vestibular 
dysfunction and experienced symptoms thereof. Apart from 
the vestibular abnormalities, the observed HI phenotype is 
similar to that of DFNA7, for which the underlying defect 
has been localized to chromosome 1q21–q23 encompass-
ing LMX1A (Fagerheim et al. 1996). Therefore, LMX1A is a 
candidate gene for DFNA7. Evaluation of rare variants seg-
regating with the HI in family 63136 revealed no strong can-
didates for being causative of the HI other than the described 
LMX1A variant.
LMX1A is a transcription factor that belongs to the highly 
conserved LIM-homeodomain protein family. LIM-home-
odomain proteins are characterized by two cysteine-rich 
zinc-binding LIM motifs that are known to be involved in 
protein–protein interactions (Kadrmas and Beckerle 2004), 
and a homeodomain that is known to bind DNA (Hobert and 
Westphal 2000). The mutated LMX1A residues identified in 
this study are located within the second LIM domain and 
the homeodomain. The p.Cys97Ser affects one of the two 
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zinc-binding residues, which is highly likely to be delete-
rious for protein folding and function. LIM-homeodomain 
transcription factors play a pivotal role in various develop-
mental processes, and can be divided into subgroups based 
on sequence similarities. The vertebrate Lmx subgroup 
consists of paralogs LMX1A and LMX1B that have identical 
homeodomain sequences (Figure S4) (Hobert and Westphal 
2000).
Bi-allelic loss-of-function variants of the murine Lmx1a 
gene cause congenital deafness, vestibular defects, and neu-
rological, skeletal, pigmentation, and reproductive system 
abnormalities (Bergstrom et al. 1999; Chizhikov et al. 2006; 
Steffes et al. 2012). However, no abnormalities in addition to 
inner ear dysfunction were observed in the studied families. 
In contrast to humans, there is no auditory phenotype in 
heterozygous Lmx1a mouse mutants, but occasionally mild 
pigmentation abnormalities are seen (Patrylo et al. 1990; 
Steffes et al. 2012). Normal hearing thresholds have been 
measured up to 16 weeks (Steffes et al. 2012) and 3 months 
(unpublished data, kindly provided by Dr. Johnson, Jack-
son Laboratory, Bar Harbor, Maine, concerning heterozy-
gous Lmx1adr-J mice). Interestingly, the genetic defect in 
the well-studied mouse model Lmx1adr-J is p.Cys82Tyr and 
affects one of the zinc-binding cysteine residues of the LIM1 
domain (Millonig et al. 2000), which supports the patho-
genicity of the identified p.Cys97Ser variant.
Heterozygous loss-of-function variants of LMX1B 
(MIM: 602575), a paralog of LMX1A, have been associ-
ated with nail–patella syndrome in human (NPS, MIM: 
161200) (Dreyer et al. 1998; McIntosh et al. 1998; Voll-
rath et al. 1998). NPS is characterized by dysplastic nails, 
absent or hypoplastic patellae, elbow dysplasia, and iliac 
horns, and may be accompanied by nephropathy and/or 
glaucoma (Mimiwati et al. 2006; Sweeney et al. 2003). 
A study by Bongers et al. (2005) indicated that late-onset 
sensorineural HI can also be associated with defects of 
LMX1B (Bongers et al. 2005). There are striking simi-
larities between the identified genetic defects of LMX1A 
and those of LMX1B. The mutated residues Cys97 and 
Val241 of LMX1A are in the sequence alignments at the 
same positions as the amino acids Cys118 and Val265 
of LMX1B, respectively (Figure S4). Amino acid vari-
ant p.Val265Leu of LMX1B is known to be disease-
causing and displays the same substitution as the LMX1A 
p.Val241Leu variant (Dunston et al. 2004). The equivalent 
of LMX1A variant p.Cys97Ser has not been identified in 
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Fig. 3  Audiometric characterization of families affected by deleteri-
ous LMX1A variants. Air conduction thresholds of both ears of the 
affected individuals are shown of first-visit and last-visit audiometry. 
The 95th percentile threshold values of presbyacusis (p95) were cal-
culated for the last-visit audiogram, and matched to the individual’s 
sex and age, according to the ISO 7029 standard. a Family W15-
0551. For subject II:7, also bone conduction thresholds of the left 
ear are depicted, because of mixed HI due to fenestral otosclerosis 
(conductive HI) and the LMX1A variant (sensorineural HI). b Fam-
ily 63136. Subjects did not participate in our clinical evaluation; only 
retrospective data were used for analysis. R right ear, L left ear
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LMX1B, but other substitutions at this position that would 
also impair the binding of a zinc atom, p.Cys118Phe 
(Vollrath et  al. 1998) and p.Cys118Tyr (Clough et  al. 
1999), and the equivalent cysteine–serine substitution in 
LIM domain 1 (p.Cys59Ser), have been associated with 
NPS. Resemblance of the identified LMX1A variants with 
disease-causing variants in LMX1B supports the former’s 
pathogenicity.
We hypothesize that the identified deleterious LMX1A 
variants lead to haploinsufficiency, which is also the pro-
posed pathogenic mechanism of NPS, caused by variants 
of LMX1B (Bongers et al. 2008; Dreyer et al. 2000; Sato 
et al. 2005). A number of LMX1B variants have been tested 
for a dominant-negative effect, including p.Val265Leu, the 
equivalent of LMX1A p.Val241Leu, but no inhibitory effect 
on wild-type protein function was found (Dreyer et al. 2000; 
Sato et al. 2005). Haploinsufficiency of LMX1A might also 
explain the sensorineural HI in a subject with a heterozy-
gous interstitial 1q23.3q24.1 deletion encompassing LMX1A 
(patient 9 in Chatron et al. 2015). However, the absence of 
an HI phenotype in mice heterozygous for loss of function 
variants of Lmx1a is not supportive of haploinsufficiency as 
the disease mechanism.
Our data do not support the suggested involvement of 
LMX1A in ID (Chatron et al. 2015; Mackenroth et al. 2016), 
as affected subjects of families W15-0551 and 63136 dis-
played normal cognition. Based on our findings and those 
of Chatron et al. (2015) and Mackenroth et al. (2016), we 
recommend screening for HI in subjects with mono-allelic 
loss of LMX1A.
In mouse, Lmx1a expression in the inner ear starts at the 
otocyst stage (from E10.5 onwards) and is later restricted 
to non-sensory epithelia of the developing cochlea and ves-
tibular system (Huang et al. 2008; Koo et al. 2009; Nichols 
et al. 2008; Steffes et al. 2012). Bi-allelic Lmx1a defects lead 
to disorganization of the inner ear and lack of differentia-
tion and separation of sensory, non-sensory and neurogenic 
domains of the vestibulocochlear system. As a result, Lmx1a 
mouse mutants have a short and malformed cochlear duct, 
no endolymphatic duct and sac, no semicircular canals, and 
the sacculus and utriculus remain rudimentary (Koo et al. 
2009; Nichols et al. 2008; Steffes et al. 2012). Hair cells in 
the basal part of the cochlea display severe disorganization, 
whereas hair cells in the apical turn are only mildly disor-
ganized (Nichols et al. 2008). Although expression of Lmx1a 
in the inner ear is reduced from E16.5 onwards (Huang et al. 
2008), Lmx1a has been suggested to function in the main-
tenance of hair cells, as there is progressive hair cell loss in 
adult mutant mice (Nichols et al. 2008).
There is large phenotypic variability within families 
W15-0551 and 63136, regarding age of onset (a)symme-
try, severity and progression rate of HI. Large intrafamil-
ial phenotypic variation has also been reported for NPS 
(Ghoumid et al. 2016). The variable HI phenotype suggests 
involvement of environmental and/or genetic factors in the 
expression of the phenotype. The expression level of the 
wild-type LMX1A allele might well be one of the genetic 
factors. The overall downsloping audiogram configuration 
observed in the affected subjects corresponds to the abnor-
mal development of the sensory epithelium in the organ of 
Corti in homozygous Lmx1a mouse mutants, displaying 
severe abnormalities of this epithelium in the basal part of 
the cochlea compared to mild defects in the apical regions 
(Koo et al. 2009).
The onset of HI caused by LMX1A defects was in the 
second or third decade in most of the cases, which sug-
gests that one LMX1A copy is sufficient for normal cochlear 
development. As homozygous Lmx1a mutant mice displayed 
loss of cochlear hair cells in the adult stage, the gene has 
been suggested to be essential for long-term maintenance 
of hair cells (Nichols et al. 2008). It is therefore tempting 
to speculate that in the families the deterioration of HI over 
time is due to progressive loss of hair cells. Since vestibular 
complaints occurred during adulthood and vestibular dys-
function seemed progressive, we speculate that LMX1A is 
also critical for maintenance of the adult vestibular organs. 
Interestingly, it has been demonstrated that both Lmx1a and 
Lmx1b not only function in the developing mouse brain, as 
expression of both genes was found to be sustained in the 
adult midbrain and to be essential for survival of adult dopa-
minergic neurons in the midbrain (Doucet-Beaupre et al. 
2016). A role in the regulation of genes with a mitochon-
drial function was indicated. It remains to be determined 
whether LMX1A, possibly in concert with LMX1B, has a 
similar function in the adult inner ear. So far, there are no 
indications for LMX1A/Lmx1a expression in the adult inner 
ear (Huang et al. 2008; Schrauwen et al. 2016). However, 
the expression might well be at a very low level and/or in 
a specific cell type. An alternative explanation for the HI 
in the presented families is that a single copy of LMX1A 
causes minor cochleovestibular developmental abnormali-
ties that eventually lead to a progressive disease-phenotype. 
The phenotype of bi-allelic deleterious LMX1A variants in 
humans is still elusive. As suggested by Steffes et al. (2012), 
bi-allelic loss-of-function variants of LMX1A might well be 
lethal in human (Steffes et al. 2012).
One of the two LMX1A variants identified in this study 
occurred de novo. Also, we identified de novo variants with 
a dominant effect to explain four of 67 cases for whom a 
genetic diagnosis was established by testing a deafness 
gene panel and Kasakura-Kimura et al. (2017) identified de 
novo variants as the cause of dominantly inherited HI in two 
of 74 ‘solved’ cases (Kasakura-Kimura et al. 2017; Zazo 
Seco et al. 2015). Interestingly, also for retinitis pigmentosa 
that displays very high genetic heterogeneity as does HI, 
the underlying genetic defect was found to be a de novo 
398 Human Genetics (2018) 137:389–400
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variant in 3 of 28 individuals without family history of the 
disease (Neveling et al. 2012). These data demonstrate that 
in families with an isolated case of a genetically highly het-
erogeneous disorder for which reproductive fitness is not 
reduced, the scenario of an underlying de novo variant is 
not uncommon.
In conclusion, mono-allelic missense variants of LMX1A 
were found to underlie nonsyndromic HI and vestibular 
defects. The HI phenotype has a variable age of onset, 
severity and progression rate. Haploinsufficiency is the most 
likely pathogenic mechanism. As in LMX1B, we expect that 
both truncating and missense variants can lead to the iden-
tified phenotype, with a preferential presence of missense 
variants in the conserved residues of the LIM domains and 
homeodomain of LMX1A.
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